Stocktoria
ELITE PHARMACEUTICALS INC /NV/ ELTP
OTC · OOTC · stock · Pharmaceutical Preparations · website · IPO 2014-02-20
ELITE PHARMACEUTICALS INC /NV/ statistics & valuation
Market cap$425.4M
P / E9.5×
P / S2.9×
P / B4.3×
P / FCF18.6×
Net margin30.1%
Return on equity45.4%
FCF margin15.3%
Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 50.4% | 47.7% | 46.5% | 48.6% | 45.9% | 46.8% | 44.3% | 37.9% | 52.9% | 38.8% |
| Operating margin | 33.0% | 23.3% | 19.1% | 10.8% | 15.7% | 8.3% | -12.7% | -121.0% | -121.4% | -76.3% |
| Net margin | 30.1% | -5.1% | 35.5% | 10.4% | 27.6% | 20.0% | -12.5% | -122.6% | -49.2% | 39.5% |
| FCF margin | 15.3% | 6.9% | -7.1% | -7.0% | 18.6% | — | — | — | — | — |
| Return on assets | 32.4% | -4.5% | 24.0% | 8.7% | 25.3% | 19.4% | -9.0% | -38.0% | -11.9% | 11.1% |
| Return on equity | 45.4% | -8.1% | 34.9% | 12.3% | 35.3% | 31.5% | -21.0% | 370.0% | -80.3% | 14.9% |
| Debt / equity | — | — | — | — | 0.05× | 0.09× | 0.15× | — | — | — |
| Current ratio | 6.45 | 4.88 | 3.07 | 2.75 | 2.82 | 2.10 | 1.19 | 1.28 | 2.68 | 5.50 |
Source: SEC EDGAR filings · CIK 0001053369 · as of 2026-03-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.